Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000422333

Medchemexpress LLC GLP-2(3-33) | 275801-62-2 | >99.8% | 3557.89 | 5 MG
SDP

Catalog No. 5000422333
Encompass_Preferred

GLP-2(3-33) is a peptide naturally generated by dipeptidylpeptidase IV (DPPIV). It functions as a partial agonist on the GLP-2 receptor with an EC50 of 5.8 nM and exhibits potential competitive antagonistic properties. This peptide has shown a binding IC50 of 41 nM in GLP-2 receptor-binding assays.

  • Naturally generated by dipeptidylpeptidase IV (DPPIV)
  • Acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM)
  • Exhibits potential competitive antagonistic properties
  • Demonstrates binding IC50 of 41 nM in GLP-2 receptor-binding assay
  • Increases dyslipidemia and hepatic lipid accumulation in HFD-fed mice in vivo

Catalog No. 50-004-22333 Supplier Medchemexpress LLC Supplier No. HYP26255MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GLP-2(3-33) is a peptide naturally generated by dipeptidylpeptidase IV (DPPIV). It functions as a partial agonist on the GLP-2 receptor with an EC50 of 5.8 nM and exhibits potential competitive antagonistic properties. This peptide has shown a binding IC50 of 41 nM in GLP-2 receptor-binding assays.

  • Naturally generated by dipeptidylpeptidase IV (DPPIV)
  • Acts as a partial agonist on GLP-2 receptor (EC50=5.8 nM)
  • Exhibits potential competitive antagonistic properties
  • Demonstrates binding IC50 of 41 nM in GLP-2 receptor-binding assay
  • Increases dyslipidemia and hepatic lipid accumulation in HFD-fed mice in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.